{
    "Trade/Device Name(s)": [
        "Dimension Vista\u2122 CTNI Flex\u00ae reagent cartridge",
        "Dimension Vista\u2122 CTNI Calibrator",
        "Dimension Vista\u2122 CTNI SDIL Sample Diluent"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K053577",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010313",
        "K010314"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI",
        "JIT"
    ],
    "Summary Letter Date": "April 14, 2006",
    "Summary Letter Received Date": "February 27, 2006",
    "Submission Date": "February 24, 2006",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac Troponin I"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Luminescent Oxygen Channeling Immunoassay (LOCI\u2122)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Calibrator",
        "Sample Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista\u2122 CTNI Flex reagent cartridge, calibrator, and sample diluent for quantitative measurement of cardiac troponin I using chemiluminescent immunoassay on the Dimension Vista\u2122 System.",
    "Indications for Use Summary": "Quantitative measurement of cardiac troponin I in human serum to aid in the diagnosis of acute myocardial infarction and risk stratification of acute coronary syndrome patients; calibrator for assay calibration; diluent for sample dilution.",
    "fda_folder": "Clinical Chemistry"
}